Your browser doesn't support javascript.
loading
Relevance of a molecular tumour board (MTB) for patients' enrolment in clinical trials: experience of the Institut Curie.
Basse, Clémence; Morel, Claire; Alt, Marie; Sablin, Marie Paule; Franck, Coralie; Pierron, Gaëlle; Callens, Céline; Melaabi, Samia; Masliah-Planchon, Julien; Bataillon, Guillaume; Gardrat, Sophie; Lavigne, Marion; Bonsang, Benjamin; Vaflard, Pauline; Pons Tostivint, Elvire; Dubot, Coraline; Loirat, Delphine; Marous, Miguelle; Geiss, Romain; Clément, Nathalie; Schleiermacher, Gudrun; Kamoun, Choumouss; Girard, Elodie; Ardin, Maude; Benoist, Camille; Bernard, Virginie; Mariani, Odette; Rouzier, Roman; Tresca, Patricia; Servois, Vincent; Vincent-Salomon, Anne; Bieche, Ivan; Le Tourneau, Christophe; Kamal, Maud.
Afiliación
  • Basse C; Department of Drug Development and Innovation, Institut Curie, Paris, France.
  • Morel C; Department of Drug Development and Innovation, Institut Curie, Paris, France.
  • Alt M; Department of Drug Development and Innovation, Institut Curie, Paris, France.
  • Sablin MP; Department of Drug Development and Innovation, Institut Curie, Paris, France.
  • Franck C; Department of Biopathology, Institut Curie, PSL Research University, Paris, France.
  • Pierron G; Department of Biopathology, Institut Curie, PSL Research University, Paris, France.
  • Callens C; Department of Biopathology, Institut Curie, PSL Research University, Paris, France.
  • Melaabi S; Department of Biopathology, Institut Curie, PSL Research University, Paris, France.
  • Masliah-Planchon J; Department of Biopathology, Institut Curie, PSL Research University, Paris, France.
  • Bataillon G; Department of Biopathology, Institut Curie, PSL Research University, Paris, France.
  • Gardrat S; Department of Biopathology, Institut Curie, PSL Research University, Paris, France.
  • Lavigne M; Department of Biopathology, Institut Curie, PSL Research University, Paris, France.
  • Bonsang B; Department of Biopathology, Institut Curie, PSL Research University, Paris, France.
  • Vaflard P; Department of Drug Development and Innovation, Institut Curie, Paris, France.
  • Pons Tostivint E; Department of Drug Development and Innovation, Institut Curie, Paris, France.
  • Dubot C; Department of Drug Development and Innovation, Institut Curie, Paris, France.
  • Loirat D; Department of Drug Development and Innovation, Institut Curie, Paris, France.
  • Marous M; Department of Drug Development and Innovation, Institut Curie, Paris, France.
  • Geiss R; Department of Drug Development and Innovation, Institut Curie, Paris, France.
  • Clément N; Department of Pediatric Oncology, Institut Curie, PSL Research University, Paris, France.
  • Schleiermacher G; Department of Pediatric Oncology, Institut Curie, PSL Research University, Paris, France.
  • Kamoun C; INSERM U900 Research Unit, Institut Curie, Paris, France.
  • Girard E; INSERM U900 Research Unit, Institut Curie, Paris, France.
  • Ardin M; INSERM U900 Research Unit, Institut Curie, Paris, France.
  • Benoist C; Department of Biopathology, Institut Curie, PSL Research University, Paris, France.
  • Bernard V; Department of Biopathology, Institut Curie, PSL Research University, Paris, France.
  • Mariani O; Department of Biopathology, Institut Curie, PSL Research University, Paris, France.
  • Rouzier R; INSERM U900 Research Unit, Institut Curie, Paris, France.
  • Tresca P; Department of Surgery, Institut Curie, PSL Research University, Paris, France.
  • Servois V; Department of Drug Development and Innovation, Institut Curie, Paris, France.
  • Vincent-Salomon A; Department of Radiology and Nuclear Medicine, Institut Curie, PSL Research University, Paris, France.
  • Bieche I; Department of Biopathology, Institut Curie, PSL Research University, Paris, France.
  • Le Tourneau C; Department of Biopathology, Institut Curie, PSL Research University, Paris, France.
  • Kamal M; EA7331, University of Paris-Descartes, Paris, France.
ESMO Open ; 3(3): e000339, 2018.
Article en En | MEDLINE | ID: mdl-29636991
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: ESMO Open Año: 2018 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: ESMO Open Año: 2018 Tipo del documento: Article País de afiliación: Francia